Skip to content
sellWeak cluster of 210b5-1 plan

Campbell Rogers sold $380k of HTFL

Chief Medical Officer at Heartflow, Inc.. 9,219 shares at an average of $41.23, traded Aug 17, 2026, filed Aug 19, 2026.

Warning score
4
Value
$380k
9,219 shares
Holdings after
86,459
-10% from before
From 52-week low
+105%
low $20.49, close $41.94
From 52-week high
-0%
high $42.08, as of Aug 17, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $380k at market
    +16
  • Share of holdings sold
    Sold 9.6% of holdings
    0
  • Cluster
    2 insiders selling within 14 days
    +8
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HTFLOct 9, 2026 · close 49.74
Since filing Aug 19, 2026: +9.2%SPY +1.4% · excess +7.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001464521-26-000135, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 17, 2026MOption exercise
Common Stock10b5-1
+9,219$19.00$175k95,678Aug 19, 2026
Aug 17, 2026SOpen-market sale
Common Stock10b5-1
-9,219$41.23$380k86,459Aug 19, 2026
Aug 17, 2026MOption exercise
Stock Optionsderivative10b5-1
-9,219$0.00$082,972Aug 19, 2026

Related signals

Other insiders at Heartflow, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
25Weak
HTFLsell 310b5-1
Heartflow, Inc.
Campbell Rogers
Chief Medical Officer
$987k
19,682 shares
-20%
47Moderate
HTFLsell 310b5-1
Heartflow, Inc.
Vikram Verghese
Chief Financial Officer
$1.2M
24,345 shares
-14%
47Moderate
HTFLsell 310b5-1
Heartflow, Inc.
Vikram Verghese
Chief Financial Officer
$1.8M
34,975 shares
-16%
50Moderate
HTFLsell 310b5-1
Heartflow, Inc.
John C.M. Farquhar
Chief Executive Officer
$1.8M
38,900 shares
-11%
32Weak
HTFLsell 310b5-1
Heartflow, Inc.
Vikram Verghese
Chief Financial Officer
$332k
6,640 shares
-3%
40Moderate
HTFLsell 210b5-1
Heartflow, Inc.
Vikram Verghese
Chief Financial Officer
$1.7M
33,416 shares
-13%
45Moderate
HTFLsell 310b5-1
Heartflow, Inc.
John C.M. Farquhar
Chief Executive Officer
$1.4M
27,230 shares
-7%
38Weak
HTFLsell 210b5-1
Heartflow, Inc.
John C.M. Farquhar
Chief Executive Officer
$1.5M
32,676 shares
-8%
33Weak
HTFLsell 210b5-1
Heartflow, Inc.
John C.M. Farquhar
Chief Executive Officer
$608k
15,560 shares
-4%
33Weak
HTFLsell 210b5-1
Heartflow, Inc.
John C.M. Farquhar
Chief Executive Officer
$639k
22,562 shares
-5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.